Clinical Trial Update: Propranolol in Angiosarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating propranolol for angiosarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angiosarcoma

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Angiosarcoma | Phase 2 | Status: COMPLETED